Patents by Inventor Robert E. Weeks

Robert E. Weeks has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6914927
    Abstract: Methods and apparatus are provided for cleaning and passivating laser discharge chambers with plasmas. In one embodiment, an oxygen based plasma is formed in a plasma source external to the laser discharge chamber by applying a radiofrequency signal to oxygen containing gases. The oxygen based plasma is drawn into the laser discharge chamber, where it reacts with contaminants and cleans internal surfaces. After cleaning, a fluorine based plasma is formed in the plasma source and drawn into the laser discharge chamber to passivate internal surfaces. In another embodiment, cleaning with the oxygen based plasma is not used since some level of cleaning is accomplished with the fluorine based plasma. In another embodiment, oxygen based plasmas and fluorine based plasmas are formed in the laser discharge chamber by applying a radiofrequency signal to a laser discharge chamber electrode.
    Type: Grant
    Filed: August 26, 2003
    Date of Patent: July 5, 2005
    Assignee: Cymer, Inc.
    Inventors: Tom A. Watson, Richard L. Sandstrom, Richard G. Morton, Robert E. Weeks, John P. Quitter, Mark R. Lewis
  • Publication number: 20040037339
    Abstract: Methods and apparatus are provided for cleaning and passivating laser discharge chambers with plasmas. In one embodiment, an oxygen based plasma is formed in a plasma source external to the laser discharge chamber by applying a radiofrequency signal to oxygen containing gases. The oxygen based plasma is drawn into the laser discharge chamber, where it reacts with contaminants and cleans internal surfaces. After cleaning, a fluorine based plasma is formed in the plasma source and drawn into the laser discharge chamber to passivate internal surfaces. In another embodiment, cleaning with the oxygen based plasma is not used since some level of cleaning is accomplished with the fluorine based plasma. In another embodiment, oxygen based plasmas and fluorine based plasmas are formed in the laser discharge chamber by applying a radiofrequency signal to a laser discharge chamber electrode.
    Type: Application
    Filed: August 26, 2003
    Publication date: February 26, 2004
    Inventors: Tom A. Watson, Richard L. Sandstrom, Richard G. Morton, Robert E. Weeks, John P. Quitter, Mark A. Lewis
  • Patent number: 6644324
    Abstract: Methods and apparatus are provided for cleaning and passivating laser discharge chambers with plasmas. In one embodiment, an oxygen based plasma is formed in a plasma source external to the laser discharge chamber by applying a radiofrequency signal to oxygen containing gases. The oxygen based plasma is drawn into the laser discharge chamber, where it reacts with contaminants and cleans internal surfaces. After cleaning, a fluorine based plasma is formed in the plasma source and drawn into the laser discharge chamber to passivate internal surfaces. In another embodiment, cleaning with the oxygen based plasma is not used since some level of cleaning is accomplished with the fluorine based plasma. In another embodiment, oxygen based plasmas and fluorine based plasmas are formed in the laser discharge chamber by applying a radiofrequency signal to a laser discharge chamber electrode.
    Type: Grant
    Filed: March 6, 2000
    Date of Patent: November 11, 2003
    Assignee: Cymer, Inc.
    Inventors: Tom A. Watson, Richard L. Sandstrom, Richard G. Morton, Robert E. Weeks, John P. Quitter, Mark R. Lewis
  • Patent number: 5311892
    Abstract: Apparatus for cleaning an object and presenting several fluids to the object for the cleaning. The apparatus has controls for sequentially and separately presenting the fluids to the object and keeping at least some of the fluids separated from each other.
    Type: Grant
    Filed: December 3, 1992
    Date of Patent: May 17, 1994
    Assignee: Cyclotron, Inc.
    Inventors: Heinz E. Adelt, Robert E. Weeks
  • Patent number: 4637981
    Abstract: Glycopeptide antibiotic A-4696G is produced by culturing Actinoplanes missouriensis mutant strain ATCC 31681 under submerged aerobic fermentation conditions, and is recovered from the fermentation broth by resin adsorption and chromatographic purification. A-4696G inhibits the growth of bacteria pathogenic to man and animals and also enhances the growth of ruminants by increasing feed utilization.
    Type: Grant
    Filed: March 26, 1984
    Date of Patent: January 20, 1987
    Assignee: Eli Lilly and Company
    Inventors: Charles L. Hershberger, Kurt E. Merkel, Robert E. Weeks, Gene M. Wild
  • Patent number: 4461723
    Abstract: Glycopeptide antibiotic A-4696G is produced by culturing Actinoplanes missouriensis mutant strain ATCC 31681 under submerged aerobic fermentation conditions, and is recovered from the fermentation broth by resin adsorption and chromatographic purification. A-4696G inhibits the growth of bacteria pathogenic to man and animals and also enhances the growth of ruminants by increasing feed utilization.
    Type: Grant
    Filed: September 29, 1982
    Date of Patent: July 24, 1984
    Assignee: Eli Lilly and Company
    Inventors: Charles L. Hershberger, Kurt E. Merkel, Robert E. Weeks, Gene M. Wild
  • Patent number: 4375513
    Abstract: Antibiotic A-4696 factors B.sub.1, B.sub.2, B.sub.3, C.sub.1a, C.sub.3, and E.sub.1 are isolated from antibiotic A-4696, the latter being produced by Actinoplanes missouriensis strains ATCC 31680, ATCC 31682, and ATCC 31683 under submerged aerobic conditions in a culture medium and isolated from the fermentation broth by absorption on an ion exchange resin and eluted therefrom at p.sup.H 10.5 with sodium hydroxide. The novel factors are separated by thin layer chromatography and high pressure liquid chromatography and have antimicrobial and growth promotant activity.
    Type: Grant
    Filed: October 9, 1981
    Date of Patent: March 1, 1983
    Assignee: Eli Lilly and Company
    Inventors: Manuel Debono, Kurt E. Merkel, Robert E. Weeks, Herald J. Cole
  • Patent number: 4322406
    Abstract: Antibiotic A-4696 factors B.sub.1, B.sub.2, B.sub.3, C.sub.1a, C.sub.3, and E.sub.1 are isolated from antibiotic A-4696, the latter being produced by Actinoplanes missouriensis strains ATCC 31680, ATCC 31682, and ATCC 31683 under submerged aerobic conditions in a culture medium and isolated from the fermentation broth by absorption on an ion exchange resin and eluted therefrom at p.sup.H 10.5 with sodium hydroxide. The novel factors are separated by thin layer chromatography and high pressure liquid chromatography and have antimicrobial and growth promotant activity.
    Type: Grant
    Filed: December 18, 1980
    Date of Patent: March 30, 1982
    Assignee: Eli Lilly and Company
    Inventors: Manuel Debono, Kurt E. Merkel, Robert E. Weeks, Herald J. Cole